Daily Sepsis Research Analysis
Analyzed 25 papers and selected 3 impactful papers.
Summary
Analyzed 25 papers and selected 3 impactful articles.
Selected Articles
1. Development and multicenter validation of an explainable machine learning diagnostic criteria for pediatric abdominal sepsis.
Using 6,566 retrospective pediatric cases for development and 308 prospectively enrolled patients across seven hospitals for external validation, the explainable ABSeD model integrating nine routine clinical variables achieved high diagnostic performance (AUC 0.934 derivation; 0.928 external). Accuracy and precision remained high in both cohorts, supporting practical early detection of pediatric abdominal sepsis.
Impact: This study closes a diagnostic gap by targeting early intra-abdominal sepsis in children with an explainable, validated model and prospective multicenter generalizability.
Clinical Implications: ABSeD can function as a decision-support triage tool to prompt earlier imaging, antibiotics, and surgical consultation in suspected pediatric abdominal sepsis, potentially reducing delays and complications.
Key Findings
- The ABSeD model using nine routine variables achieved AUC 0.934 (95% CI 0.912–0.950) in derivation and 0.928 (95% CI 0.895–0.961) in multicenter prospective validation.
- High accuracy was maintained in both datasets (derivation accuracy 0.870, precision 0.910; external accuracy 0.873, precision 0.924).
- Explainability enabled transparent feature contributions, supporting clinical adoption for early pediatric abdominal sepsis detection.
Methodological Strengths
- Prospective multicenter external validation across seven hospitals
- Explainable model using nine routine, readily available clinical variables
Limitations
- Derivation cohort was single-center and retrospective
- External validation size (n=308) and short enrollment window may limit generalizability beyond included regions
Future Directions: Prospective impact studies to assess clinical workflow integration, time-to-antibiotics/surgery, and outcome benefits; broader international validation and model updating.
Accurate identification of early pediatric abdominal sepsis (PAS) is essential to improving outcomes, yet most existing pediatric sepsis criteria and scoring tools primarily focus on cardiopulmonary dysfunction and overlook early intra-abdominal infections. To address this gap, we combined the real-world data with explainable machine learning to develop the Abdominal Sepsis Diagnosis model (ABSeD) for clinical decision support. The model construction used the retrospective data from 6566 pediatric patie
2. Evaluating deep learning sepsis prediction models in ICUs under distribution shift: a multi-centre retrospective cohort study.
Across 216,536 ICU stays from HiRID, MIMIC-IV, and eICU, routine fine-tuning underperformed for sepsis prediction under distribution shift. Retraining and fusion-training were superior with small and large target datasets, whereas supervised domain adaptation delivered the most stable gains with medium target data, improving AUROC and normalized AUPRC versus other strategies.
Impact: By rigorously benchmarking deployment strategies across harmonized multi-center datasets, this study reframes how sepsis prediction models should be transferred and deployed in real ICUs.
Clinical Implications: ICUs should avoid routine fine-tuning when porting sepsis prediction models. Strategy selection should depend on target data availability: retraining/fusion for small/large datasets and supervised domain adaptation for medium-sized datasets.
Key Findings
- Distribution shifts quantified across HiRID, MIMIC-IV, and eICU (216,536 stays) led to generalization failures of standard models.
- Fine-tuning consistently underperformed versus alternatives across multiple architectures.
- Retraining and fusion-training performed best for small and large target data, while supervised domain adaptation delivered the most stable gains with medium target data, improving AUROC and normalized AUPRC.
Methodological Strengths
- Large, harmonized multi-cohort evaluation across three major ICU datasets
- Systematic comparison of five deployment strategies across data regimes and architectures
Limitations
- Retrospective design without assessment of real-time clinical impact on care or outcomes
- Adult ICU cohorts only; results may not generalize to pediatrics or non-ICU settings
Future Directions: Prospective, interventional evaluations of deployment strategies measuring workflow integration, alert burden, clinician response, and patient outcomes across diverse hospitals.
Sepsis prediction models trained on ICU data often fail to generalize under external validation because of distribution shift. Prior studies have focused on direct model deployment or conventional transfer learning methods (e.g., fine-tuning), yet systematic exploration of alternative strategies remains limited. We quantify shifts across three harmonized adult ICU cohorts (HiRID, MIMIC-IV, eICU; 216,536 stays) and compare five deployment strategies: generalization, fine-tuning/retraining, target
3. Diagnostic Performance of Point-of-Care Immunoassay Measurements of Pancreatic Stone Protein for Sepsis Detection in ICU Patients: A Prospective, Multicenter, Biomarker-Blinded Study.
In 466 ICU adults across six US centers, point-of-care PSP measured within the first 3 days showed balanced performance (sensitivity 74.2%, specificity 67.8% at 117 ng/mL). Combining PSP with CRP markedly improved specificity to 95.2%, with consistent subgroup performance, supporting PSP as a broadly applicable early sepsis biomarker.
Impact: Provides multicenter, biomarker-blinded, point-of-care evidence for PSP, and demonstrates additive value with CRP, informing practical early sepsis identification.
Clinical Implications: PSP can be incorporated into early ICU sepsis screening, particularly when combined with CRP to enhance specificity, potentially reducing unnecessary antibiotic exposure while prompting timely treatment for true sepsis.
Key Findings
- At a PSP cutoff of 117 ng/mL, sensitivity was 74.2% and specificity 67.8% (accuracy 71.0%; LR+ 2.30; LR− 0.38).
- Combining PSP with CRP increased diagnostic specificity to 95.2%.
- Subgroup analyses showed consistent performance across sex and higher specificity in patients aged 18–60; febrile patients had high specificity (87.5%) with lower sensitivity (63.6%).
Methodological Strengths
- Prospective, multicenter, biomarker-blinded design
- Pre-specified performance evaluation with Youden Index thresholding and subgroup analyses
Limitations
- Observational design without assessment of outcome impact from PSP-guided decisions
- Threshold derived within the study may require external calibration; moderate sensitivity/specificity when used alone
Future Directions: Randomized or stepped-wedge trials to test PSP±CRP-guided pathways on time-to-antibiotics, antimicrobial stewardship, and patient-centered outcomes; external calibration across diverse ICUs.
OBJECTIVES: To evaluate the diagnostic performance of a rapid point-of-care immunoassay measuring pancreatic stone protein (PSP) for early sepsis identification within the first three days of ICU admission. Subgroup analyses (sex, age, febrile status) were conducted, and the combined diagnostic value of PSP and C-reactive protein (CRP) was assessed. DESIGN: Multicenter, prospective, observational study. PATIENT: Four hundred sixty-six adults the ICU. SETTING: Six ICUs in the United States who were e